Algert Global LLC Abiomed Inc Transaction History

Algert Global LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 15, 2022	SELL	$242.49 - $301.46 $82,446 - $102,496	-340 Reduced 7.23%	4,363 $1.07 Million
Q2 2022 Aug 15, 2022	BUY	$224.73 - $338.64 $158,434 - $238,741	705 Added 17.63%	4,703 $1.16 Million
Q1 2022 May 16, 2022	BUY	$277.25 - $366.29 $1.11 Million - $1.46 Million	3,998 New	3,998 $1.32 Million
Q2 2019 Aug 14, 2019	SELL	$250.96 - $284.94 $451,728 - $512,892	-1,800 Closed	0 $0
Q1 2019 May 01, 2019	SELL	$276.39 - $362.25 $298,501 - $391,230	-1,080 Reduced 37.5%	1,800 $514,000
Q4 2018 Feb 01, 2019	BUY	$281.08 - $444.25 $809,510 - $1.28 Million	2,880 New	2,880 $936,000

137K

Ticker ABMD
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 45,460,900
Description
Abiomed, Inc. engages in the research, development, and sale of medical devices to assist or replace the pumping function of the failing heart. It also provides a continuum of care to heart failure patients. The company offers Impella 2.5, a percutaneous micro heart pump with integrated motor and sensors; and Impella CP, a device for use by inte...

Get notified when there are updates to the investment portfolio of Algert Global LLC, based on Form 13F filings with the SEC.

Stay updated on Algert Global LLC with notifications on news.